Reata Pharmaceuticals, Inc.
RETA · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $193 | -$116 | -$86 | -$79 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$292 | $0 | $0 | $0 |
| Stock-Based Comp. | $20 | $38 | $15 | $14 |
| Change in WC | $2 | -$13 | $11 | $8 |
| Other Non-Cash | $7 | $9 | $9 | $10 |
| Operating Cash Flow | -$70 | -$81 | -$50 | -$47 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $75 | $0 |
| Inv. Purchases | -$240 | -$64 | -$184 | -$144 |
| Inv. Sales/Matur. | $197 | $175 | $245 | $0 |
| Other Inv. Act. | $0 | $0 | -$75 | $75 |
| Investing Cash Flow | -$43 | $111 | $61 | -$69 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $109 | $0 | $0 | $113 |
| Stock Repurch. | $23 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $13 | $0 | $0 |
| Financing Cash Flow | $77 | $13 | $0 | $0 |
| Forex Effect | $168 | $0 | $0 | $0 |
| Net Chg. in Cash | -$36 | $43 | $10 | -$115 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $85 | $42 | $32 | $147 |
| End Cash | $49 | $85 | $42 | $32 |
| Free Cash Flow | -$70 | -$82 | -$51 | -$47 |